Related Experiment Video
Updated: Aug 8, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season
Jeffrey C Hageman1, Timothy M Uyeki, John S Francis
1Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. JHageman@cdc.gov
Abstract:
During the 2003-04 influenza season, 17 cases of Staphylococcus aureus community-acquired pneumonia (CAP) were reported from 9 states; 15 (88%) were associated with methicillin-resistant S. aureus (MRSA). The median age of patients was 21 years; 5 (29%) had underlying diseases, and 4 (24%) had risk factors for MRSA. Twelve (71%) had laboratory evidence of influenza virus infection. All but 1 patient, who died on arrival, were hospitalized. Death occurred in 5 (4 with MRSA). S. aureus isolates were available from 13 (76%) patients (11 MRSA). Toxin genes were detected in all isolates; 11 (85%) had only genes for Panton-Valentine leukocidin. All isolates had community-associated pulsed-field gel electrophoresis patterns; all MRSA isolates had the staphylococcal cassette chromosome mec type IVa. In communities with a high prevalence of MRSA, empiric therapy of severe CAP during periods of high influenza activity should include consideration for MRSA.
Insights
Severe community-acquired pneumonia (CAP) during flu season is often linked to methicillin-resistant Staphylococcus aureus (MRSA). Early consideration of MRSA in treatment is crucial, especially in high-prevalence areas.
Area of Science:
- Infectious Diseases
- Pulmonology
- Microbiology
Background:
- Community-acquired pneumonia (CAP) poses a significant health burden.
- Staphylococcus aureus, particularly methicillin-resistant strains (MRSA), is an emerging cause of severe CAP.
- Influenza virus coinfection is increasingly recognized in severe bacterial pneumonia.
Purpose of the Study:
- To investigate the characteristics and outcomes of Staphylococcus aureus CAP cases during the 2003-04 influenza season.
- To identify risk factors and microbiological features associated with MRSA in severe CAP.
- To inform clinical management strategies for severe CAP during influenza outbreaks.
Main Methods:
- Retrospective analysis of 17 S. aureus CAP cases reported across 9 states during the 2003-04 influenza season.
- Clinical data collection including patient demographics, underlying conditions, risk factors, and outcomes.
- Microbiological characterization of S. aureus isolates, including antibiotic susceptibility, toxin gene profiling (Panton-Valentine leukocidin), and molecular typing (PFGE, SCCmec).
- Laboratory confirmation of influenza virus infection.
Main Results:
- 17 S. aureus CAP cases were identified; 15 (88%) were MRSA.
- The median patient age was 21 years, with 29% having underlying diseases and 24% having MRSA risk factors.
- Influenza virus infection was present in 71% of patients.
- The overall mortality rate was 29% (5 deaths), with 4 deaths attributed to MRSA.
- All S. aureus isolates carried toxin genes, predominantly Panton-Valentine leukocidin (85%).
- MRSA isolates exhibited community-associated PFGE patterns and SCCmec type IVa.
Conclusions:
- Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of severe community-acquired pneumonia (CAP), especially when associated with influenza virus infection.
- The genotypic and phenotypic characteristics of these MRSA isolates are consistent with community-acquired strains.
- Empiric antibiotic therapy for severe CAP during influenza seasons in areas with high MRSA prevalence should include coverage for MRSA.
More Related Videos
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
13:45A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia
Published on: September 21, 2019
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Influenza
Pneumonia II: Pathophysiology
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia III: Complications and Assessment